Table 2.
Clinical data of patients in high serum TG group and normal TG group
| Clinical data | TG<2.3 | TG≥2.3 | t/U/χ2 | P |
|---|---|---|---|---|
| Sex (M/F) | 34/25 | 3/5 | 1.154 | 0.283 |
| Age (y) | 45.3±17.6 | 44.4±11.9 | 0.139 | 0.890 |
| TPNT | 18.9±9.2 | 14.4±4.0 | 2.461 | 0.023* |
| Clinical types | 1.830 | 0.608 | ||
| Mild | 20 | 1 | ||
| Moderate | 34 | 6 | ||
| Severe | 5 | 1 | ||
| Complications | ||||
| Bacterial infection | 5/54 | 1/7 | 0.140 | 0.708 |
| Diabetes | 6/53 | 1/7 | 0.041 | 0.840 |
| Hypertension | 12/47 | 1/7 | 0.277 | 0.599 |
| Treatment | ||||
| Abidol (Y/N) | 35/24 | 4/4 | 0.252 | 0.616 |
| Interferon (Y/N) | 51/8 | 7/1 | 0.007 | 0.934 |
| Thymosin (Y/N) | 15/44 | 1/7 | 0.647 | 0.421 |
| Glucocorticoid (Y/N) | 14/45 | 4/4 | 2.475 | 0.116 |
| Laboratory findings | ||||
| AST (U/L) | 28.1±17.8 | 28.0±5.5 | 0.002 | 0.998 |
| ALT (U/L) | 38.2±30.1 | 40.3±21.7 | -0.185 | 0.854 |
| LDH (U/L) | 215.0±79.7 | 209.1±30.1 | 0.687 | 0.492 |
| Alb (g/L) | 43.7±5.6 | 42.0±3.8 | 0.838 | 0.405 |
| Glu (mmol/L) | 6.4±1.7 | 7.5±2.0 | -1.330 | 0.191 |
| TC (mmol/L) | 3.93 (2, 7) | 3.93 (3, 4) | -0.276 | 0.789 |
| TG (mmol/L) | 1.05 (0.57, 2.25) | 2.96 (2.41, 5.22) | 4.556 | -0.000* |
| WBC (109/L) | 5.33±1.9 | 5.9±2.6 | -0.766 | 0.446 |
| N (109/L) | 3.6±1.7 | 3.3±1.2 | 0.357 | 0.723 |
| CRP (mg/L) | 6.8 (0, 174.6) | 9.2 (1.74, 63.8) | 0.619 | 0.536 |
| IL-6 (pg/ml) | 9 (2, 62) | 4.5 (2, 12) | -1.179 | 0.250 |
| Ferritin (ng/ml) | 396.3 (39, 1848) | 422.1 (339, 578) | 0.17 | 0.902 |
| NLR | 2.86 (1.12, 22.15) | 2.85 (1.86, 6.69) | 0.26 | 0.803 |
*
P<0.05.